REVIVAL OF MICROBIAL THERAPEUTICS, WITH EMPHASIS ON PROBIOTIC LACTOBACILLUS (REVIEW).

E Kakabadze, N Grdzelishvili, L Sanikidze, Kh Makalatia, N Chanishvili

Journal: Georgian medical news 2021

PMID: 33395654

Abstract

The idea to use living microorganisms for disease prevention and treatment was introduced a century ago, but yet the full potential and benefits of microbial therapeutics has not been entirely understood. In the light of developments of human microbiome studies, probiotics are gaining new momentum, where health benefit conferring by Lactobacillus are emerging as one of the novel approaches in the treatment and prophylactics of dysbiosis. The present review focuses on the origin and development of the probiotic's concept, mechanisms of action and anticipated use of probiotic Lactobacillus as well as of microbial therapeutics. The required regulatory frameworks associated with probiotic use and marketing are discussed.

Address: 1Tbilisi State University, Faculty of Exact and Natural Science; 2George Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia.; 2George Eliava Institute of Bacteriophage, Microbiology and Virology; 3Ilia State University, School of Natural Sciences and Engineering, Tbilisi, Georgia.; 1Tbilisi State University, Faculty of Exact and Natural Science, Georgia.; 1Tbilisi State University, Faculty of Exact and Natural Science; 2George Eliava Institute of Bacteriophage.; 2George Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.